Lactobacillus fermentum Lf 2 produces large amounts of exopolysaccharides under 28 optimized conditions (~2 g/L, EPS) which have been shown to possess 29 immunomodulatory activity. In this study, the crude EPS was fractionated to give a 30 high molecular weight (HMw) homoglycan and a mixture of medium molecular 31 weight heteroglycans. The HMw EPS was isolated and identified as a -glucan. 32 Peripheral blood mononuclear cells (PBMC) were pre-treated with purified 33 polysaccharide to determine if the HMw -glucan is responsible for the 34 immunomodulatory activity. Cells were also stimulated with either lipopolysaccharide 35 (LPS) or phytohemagglutinin (PHA) and their effects, both with and without -glucan 36 pre-treatment, compared.
The results indicate a role for the bacterial -glucan in modulating the immune 48 response following exposure to agonists such as bacterial LPS. 49 The location of the ring protons was identified through inspection of a combination of 137 1 H-1 H-COSY and 1 H-1 H-TOCSY spectra (see supplementary information) and that of 138 the ring carbons using a combination of a 1 H-13 C-HSQC-spectrum and a 1 H-13 C-139 HSQC-TOCSY spectrum (see supplementary information). The chemical shifts for 140 the proton and carbons are listed in Table 1 . U.V. absorption and 31 P NMR spectra were recorded for the HMw polysaccharide 147 and these were not able to detect any phosphorous, protein or nucleic acid, and 148 when taken along with the results of the other characterization studies, this 149 confirmed that a high purity polysaccharide had been isolated.
150
PBMC isolation and cell culture. In the Day 1 experiment PBMC were 151 activated by treatment with the HMw -glucan in all the donors (p < 0.001 -0.0001) 152 (Fig 3) . The levels of activation, compared to the control, were comparable for both 153 -glucan concentrations used (50 µg/mL and 100 µg/mL), except for Donor B where 154 higher levels were obtained for 50 µg/mL EPS (p < 0.0001). 155 In the Day 2 experiment, levels of activation remained elevated in the -glucan Apparent anomalies in the MTS results were observed for PHA treatment, where 162 although a statistically significant activation was observed for two out of three donors 163 tested (p < 0.05-0.01), the recorded levels did not correspond to the level of cell 164 proliferation observed on microscopic images for this condition (Fig 4) . It is possible 165 that the conditions used for PHA stimulation interfered with the results of the MTS 166 assay such that the level of metabolic activity that this assay measured did not 167 accurately correspond to the level of proliferation exhibited after PHA stimulation (28; Microscopic inspection of the cells (Fig 4) confirmed the high levels of proliferation 171 and clumping of cells after PHA stimulation when compared to the unstimulated and 172 untreated condition ( Fig 4A) and the degree of cell aggregation was attenuated by 173 previous treatment with -glucan ( Fig 4C) . Absorbance values measured by MTS 174 assay confirmed the difference between PHA only stimulated condition compared to 175 the EPS pre-treated and PHA stimulated condition, at least in Donors B and C, 176 however, the levels were lower than what would be expected for the higher 177 proliferation visible in the images of PHA stimulated PBMC. for two out of three donors CD14 showed lower expression after pre-treatment with 183 EPS compared to the untreated condition, regardless of the concentration used (p < 184 0.0001, Fig 5) . In the second experiment, at Day 2, however, initial pre-treatment 185 with EPS led to a robust increase in the CD14 expression, for all conditions, 186 compared to those that had not been pre-treated with EPS (untreated unstimulated 187 vs EPS pre-treated; LPS stimulated vs EPS pre-treated and LPS stimulated, with p < 188 0.0001 in all cases, and in Donor B only, PHA stimulated vs EPS pre-treated and 189 PHA stimulated, p < 0.01; Fig 5B) The effect of PBMC stimulation on TLR-2 expression was less consistent and the 198 only result of note is that there was a clear decrease at Day 2 in TLR-2 expression 199 after EPS pre-treatment, followed by LPS stimulation, compared to the LPS 200 stimulated alone (p< 0.05 for Donor C and p < 0.0001 for Donors A and B, Fig 6) .
201
[Insert Figure 6 here] 202 Stimulation of TNF-α secretion. Initial treatment with EPS resulted in an increase 203 in TNF-α secretion on Day 1 for both concentrations ( Fig 7A) . However, while in 204 Donors B and C the increase in TNF-α was greater for the lower EPS concentration 205 (50 µg/ml), the opposite was true for Donor A (Fig 7A) . 206 Interestingly, TNF- levels in the Day 2 experiment for the cells that were pre-treated 207 with EPS at Day 0 and then left unstimulated at Day 1 were comparable to control 208 cells ( Fig 7B) indicating a robust decrease in the levels of this cytokine when 209 compared to EPS pre-treated conditions in the Day 1 experiment ( Fig 7A) . For cells 210 that were treated with EPS on Day 0 and then stimulated on Day 1 with LPS or PHA 211 the pre-treatment with EPS greatly attenuated a robust increase in TNF-α secretion 212 for all donors (p < 0.01 between LPS and EPS+LPS in Donor B, and p < 0.0001 213 between PHA and EPS+PHA in Donors A and C). The aim of this study was determine which component of the bacterial EPS produced 218 by L. fermentum Lf2 is responsible for the immunomodulatory properties of the crude 219 EPS and to gain an understanding of the nature of this modulation. Analysis indicated 220 that the crude EPS included both a HMw polysaccharide and a mixture of medium 221 molecular weight polysaccharides that were separated by size exclusion 222 chromatography. The HMw polysaccharide was identified as a -glucan with a weight 223 average molecular mass (1.23 x 10 6 Da) which is similar to that of EPS obtained from 224 other strains of lactic acid bacteria (LAB) (30; 31). Using NMR analysis, the 1 H and 225 13 C-chemical shifts were recorded for the -glucan (Table 1) these are identical to 226 those published for the EPS isolated from Pediococcus damnosus 2.6 (26),
227
Oenococcus oeni I4 (32) and for one of the two EPSs produced by Lactobacillus sp. It is worth noting that the repeating unit is similar to the type 37 polysaccharide 237 produced by Streptococcus pneumoniae which has the same linear backbone ( →3)-238 β-D-Glcp-(1→ ) bearing a terminal glucose unit at the 2-position but these appear on 239 each residue in the S. pneumoniae EPS, rather than on alternate residues as in the L. 240 fermentum Lf2 -glucan (33). All attempts to purify the medium molecular weight 241 polysaccharide were unsuccessful, the on-going work to characterise this material will 242 be reported elsewhere.
243
Treatment of PBMC with the -glucan had no impact on cell viability but did increase 244 the metabolic activity of cells that was measured as an increase in mitochondrial Lactobacillus gasseri strains G10 and H15 had no effect on the proliferation of the 260 cervical cancer cell line HeLa (39). These differences are not surprising since it has 261 previously been demonstrated that EPS can exert a differential effect on the 262 metabolic activity of different cell types (40).
263
The MTS assays gave results in agreement with previous reports, where the optimal 264 PHA concentration for cell stimulation was 2.5µg and where only modest increase in 265 metabolic activity was reported for cultures stimulated with 10µg/ml PHA (28). From inspection of the microscope images it is clear that pre-treatment with the -glucan 267 partially reversed the effect of PHA by reducing the amount of cell clumping.
268
Changes in cytokine production in response to the presence of microbial strains and 269 their products is a way of demonstrating immunomodulatory effect on host cells. For to 24-well plates (Starlab, UK). The cells were then challenged as shown in Figure   384 8. For the Day 1 experiment (Fig 8A) , cells were treated with two different 385 concentrations of EPS (50 µg/mL and 100µg/mL) or left untreated, four replicates 386 were set up for each condition. For the Day 2 experiment (Fig 8B) , at Day 0, half of 387 the wells were treated with 100 µg/mL EPS while the other half was left untreated.
388
Cells were incubated for 24 h, at 37 ˚C, 5% CO2 after which they were washed with 389 supplemented RPMI 1640 and stimulated with either LPS (Lipopolysaccharides from 390 Escherichia coli O111:B4) at a final concentration of 100 ng/mL or PHA-M (Lectin 391 from Phaseolus vulgaris (red kidney bean)) at 10 µg/ml, or left unstimulated ( Fig 8B) . washes, non-specific binding was blocked using blocking buffer after which samples 420 were added and incubated for 2 h at room temperature. Plates were then washed 421 and biotinylated detection antibody was added, after which avidin horseradish 422 peroxidase (avidin-HRP) was used to bind to the biotin on the detection antibody. Tetra-methyl benzidine was then added as the substrate for the HRP enzyme, and 424 the reaction was stopped with the addition of 1M sulfuric acid. Absorbance was read 425 at 495nm using FLUOstar Optima plate reader (BMG Labtech). The data were 426 analysed using MARS Data Analysis Software, and a 4 parameter logistic regression 427 curve was used as the best fit for the data. The residual HOD signal is at 4.29 ppm at 70 o C. Figure 3 . Non-radioactive MTS assay was used for measuring metabolic activity of the cells under different culture conditions as measured after A. Experiment 1, Day 1 and B. Experiment 2, Day 2. For Experiment 1, Unstimulated conditions were left untreated while Lf2 HMw 50µg/ml and Lf2 HMw 100µg/ml were treated with EPS at indicated concentrations on Day 0 and incubated at 37˚C, 5% CO 2 . Following 24h incubation, cells were harvested and 1x10 5 cells/well were transferred into 96-well plates for MTS assay performed following the supplier's instructions. For Experiment 2, Day 2, Unstimulated condition was left untreated on Day 0 then washed and left unstimulated on Day 1. Lf2 HMw 100µg/ml were pre-treated at Day 0 with indicated concentration of EPS, then washed and left unstimulated on Day 1. LPS and PHA alone are conditions that were left untreated on Day 0, then washed and subsequently stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively. EPS + LPS and EPS + PHA represent the conditions that were pre-treated with EPS Lf2 HMw on Day 0, washed and stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively on Day 1. Following 24h incubation, cells were harvested and 1x10 5 cells/well were transferred into 96-well plates for MTS assay performed following the supplier's instructions. Two-Way ANOVA was used to compare the conditions for each donor. Data are presented as Mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 when compared to the untreated, unstimulated condition; # p < 0.05, ### p < 0.001, #### p < 0.0001 when compared between two indicated conditions. Figure 5 . Changes in CD14 expression on PBMC following different conditions presented as median fluorescence intensity (MFI) of CD14 + cells after A. Day 1 and B. Day 2 experiment. For Day 1, Unstimulated conditions were left untreated while Lf2 HMw 50µg/ml and Lf2 HMw 100µg/ml were treated with EPS at indicated concentrations on Day 0 and incubated at 37˚C, 5% CO 2 . Following 24h incubation, cells were harvested and stained with anti-CD14 antibody and analysed by flow cytometry. For Day 2 experiment, Unstimulated condition was left untreated on Day 0, then washed and left unstimulated on Day 1. Lf2 HMw 100µg/ml were pre-treated at Day 0 with indicated concentration of EPS, then washed and left unstimulated on Day 1. LPS and PHA alone are conditions that were left untreated on Day 0, then washed and subsequently stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively. EPS + LPS and EPS + PHA represent the conditions that were pre-treated with EPS Lf2 HMw on Day 0, then washed and stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively on Day 1. Following 24h incubation, cells were harvested and stained with anti-CD14 antibody and analysed by flow cytometry. Two-Way ANOVA was used to compare the conditions for each donor. Data are presented as Mean ± SEM. * p < 0.05, *** p < 0.001, **** p < 0.0001 when compared to the untreated, unstimulated condition; # p < 0.05, ## p < 0.01, #### p < 0.0001 when compared between two indicated conditions. Gates were set on single cells and debris was excluded using FSC vs SSC plots. Gating was performed using FMO (Fluorescence Minus One) controls. Figure 6 . Changes in TLR-2 expression on PBMC following different conditions presented as median fluorescence intensity (MFI) of TLR-2 + cells after A. Day 1 and B. Day 2 experiment. For Day 1, Unstimulated conditions were left untreated while Lf2 HMw 50µg/ml and Lf2 HMw 100µg/ml were treated with EPS at indicated concentrations on Day 0 and incubated at 37˚C, 5% CO 2 . Following 24h incubation, cells were harvested and stained with anti-TLR-2 antibody and analysed by flow cytometry. For Day 2 experiment, Unstimulated condition was left untreated on Day 0, then washed and left unstimulated on Day 1. Lf2 HMw 100µg/ml were pre-treated at Day 0 with indicated concentration of EPS, then washed and left unstimulated on Day 1. LPS and PHA alone are conditions that were left untreated on Day 0, then washed and subsequently stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively. EPS + LPS and EPS + PHA represent the conditions that were pre-treated with EPS Lf2 HMw on Day 0, then washed and stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively on Day 1. Following 24h incubation, cells were harvested and stained with anti-TLR-2 antibody and analysed by flow cytometry. Two-Way ANOVA was used to compare the conditions for each donor. Data are presented as Mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 when compared to the untreated, unstimulated condition; # p < 0.05, #### p < 0.0001 when compared between two indicated conditions. Gates were set on single cells and debris was excluded using FSC vs SSC plots. Gating was performed using FMO (Fluorescence Minus One) controls. Figure 7 . Changes in TNF-α levels in cell culture supernatants following different conditions after A. Day 1 and B. Day 2 experiment. For Day 1, Unstimulated conditions were left untreated while Lf2 HMw 50µg/ml and Lf2 HMw 100µg/ml were treated with EPS at indicated concentrations on Day 0 and incubated at 37˚C, 5% CO 2 . Following 24h incubation, supernatants were stored at -80˚C until subsequent analysis for TNF-α levels by ELISA. For Day 2 experiment, Unstimulated condition was left untreated on Day 0, then washed and left unstimulated on Day 1. Lf2 HMw 100µg/ml were pre-treated at Day 0 with indicated concentration of EPS, then washed and left unstimulated on Day 1. LPS and PHA alone are conditions that were left untreated on Day 0, then washed and subsequently stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively. EPS + LPS and EPS + PHA represent the conditions that were pretreated with EPS Lf2 HMw on Day 0, then washed and stimulated with 100ng/ml LPS and 10µg/ml PHA, respectively on Day 1. Following 24h incubation, supernatants were stored at -80˚C until subsequent analysis for TNF-α levels by ELISA. Two-Way ANOVA was used to compare the conditions for each donor. Data are presented as Mean ± SEM. ** p < 0.01, **** p < 0.0001 when compared to the untreated, unstimulated condition; # p < 0.05, ## p < 0.01, #### p < 0.0001 when compared between two indicated conditions. A B Figure 8 . Schematic representation of the cell culture protocol completed on A. Experimet 1 and B. Experiment 2. A. On Day 0, cells were treated with two different Lf2 HMw EPS concentrations (50µg/ml and 100µg/ml) or left untreated at 37˚C, 5% CO 2 . Following 24h incubation, supernatants were taken off and stored at -80˚C for subsequent analysis by ELISA. Cells were harvested and 1x10 5 cells/well were transferred into 96-well plates for MTS assay performed following the supplier's instructions. The remaining cells were stained with antibodies for CD14 and TLR-2 and analysed for the expression of these markers by flow cytometry. B. on Day 0 cells were pre-treated with 100µg/ml EPS or left untreated and incubated for 24h at 37˚C, 5% CO 2 . On Day 1, cells were washed to remove EPS and were stimulated with LPS (100ng/ml) or PHA (10µg/ml) or left unstimulated and incubated for another 24h at 37˚C, 5% CO 2. On Day 2, supernatants were then stored at -80˚C for subsequent cytokine analysis by ELISA. As before 1x10 5 of harvested cells/well were transferred into 96well plate for MTS assay while remaining cells were stained for flow cytometric analysis of CD14 and TLR-2 expression. Supplementary Data: Figure S1 : 1 H-1 H COSY spectrum for the HMw -glucan recorded in solution in D2O (5-10 mg in 0.65 mL) at 70 o C on a Bruker 500MHz spectrometer, Labels (A-C) identify the different monosaccharides and the numbers(1-3) identify the respective proton/carbon. A1 B1/C1 A2 C2 B2 A3 A4 B3 C3 A2 Figure S2 : 1 H-1 H TOCSY spectrum for the HMw -glucan recorded in solution in D2O (5-10 mg in 0.65 mL) at 70 o C on a Bruker 600MHz spectrometer, Labels (A-C) identify the different monosaccharides and the numbers (1-6) identify the respective proton/carbon.
A1
A2 A4 A3/A5 A6 A6 B1/C1 B3/B6 B2 B6 B4/B5 C6 B2 C6 C2 C4/C5 Figure S3 : 1 H-1 H HSQC spectrum for the HMw -glucan recorded in solution in D2O (5-10 mg in 0.65 mL) at 70 o C on a Bruker 500MHz spectrometer, Labels (A-C) identify the different monosaccharides and the numbers (1-6) identify the respective proton/carbon. Figure S5 : 13 C-1 H HSQC-HMBC spectrum for the HMw -glucan recorded in solution in D2O (5-10 mg in 0.65 mL) at 70 o C on a Bruker 500MHz spectrometer, Labels identify the significant inter and intra residue scalar coupling, those involved in linkages are highlighted in bold; (A-C) identify the different monosaccharides and the numbers (1-6) identify the respective proton/carbon.
B2-A1
B3-B2 C3-B1
B2-B3
A1-A2 C1-C2 A1 B1 C1 C3 B3 B2 B1-B2
B1-B3
C1-C3
B3-C1
C3-C2 Figure S6 : 1 H-1 H ROESY spectrum for the HMw -glucan recorded in solution in D2O (5-10 mg in 0.65 mL) at 70 o C on a Bruker 500MHz spectrometer, Labels the significant inter and intra residue NOEs-those locating linkages are highlighted in bold involved (A-C) identify the different monosaccharides and the numbers (1-6) identify the respective proton/carbon.
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